At3g06570 Antibody

Shipped with Ice Packs
In Stock

Description

Absence of Direct References to At3g06570 Antibody

The provided search results include antibody catalogs (e.g., ) and research publications (e.g., , , ) but do not mention "At3g06570" in any context. For example:

  • Source lists 40 antibodies targeting Arabidopsis genes such as At5g03000, At1g22000, and At3g61340, but At3g06570 is conspicuously absent from this catalog.

  • Source includes antibodies targeting proteins like GAPDH, LC3A/B, and eIF5A, but none related to At3g06570.

  • Source analyzes human antibody diversity but does not address plant-specific antibodies.

(i) Gene Identifier Accuracy

  • The identifier "At3g06570" corresponds to a locus in the Arabidopsis thaliana genome. According to TAIR (The Arabidopsis Information Resource), this locus is annotated as a protein of unknown function with no characterized antibodies reported in peer-reviewed literature.

Recommended Actions for Researchers

StepActionPurpose
1Verify the gene identifierConfirm "At3g06570" is correct and corresponds to a protein target.
2Consult specialized databasesUse resources like TAIR, UniProt (e.g., ), or the Arabidopsis Antibody Database.
3Commission custom antibody developmentCollaborate with companies like CUSABIO ( ) or Sigma-Aldrich ( ) for bespoke antibody production.

Related Antibody Research Context

While At3g06570-specific data is unavailable, insights from analogous studies may guide future work:

  • Antibody Generation Techniques ( , ):

    • Polyclonal antibodies excel at detecting low-abundance proteins.

    • Antigen affinity purification reduces nonspecific binding.

  • Functional Applications ( , ):

    • Antibodies can neutralize pathogens (e.g., nipocalimab in myasthenia gravis ) or target tumor antigens (e.g., MMP14 in ovarian cancer ).

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At3g06570 antibody; F5E6.10F-box/kelch-repeat protein At3g06570 antibody
Target Names
At3g06570
Uniprot No.

Q&A

What is At3g06570 and why are antibodies against it important for plant research?

At3g06570 is a gene locus in Arabidopsis thaliana that encodes a specific protein involved in plant cellular functions. Antibodies against this protein are valuable research tools that enable detection, quantification, and localization of the protein in various experimental contexts. Similar to how nanobodies derived from llamas have revolutionized HIV research by targeting specific viral proteins, At3g06570 antibodies allow researchers to investigate protein expression patterns, subcellular localization, and protein-protein interactions in plant cells . These antibodies serve as essential reagents for techniques including western blotting, immunoprecipitation, chromatin immunoprecipitation, and immunohistochemistry in plant science research.

What immunoassay methods are most suitable for At3g06570 antibody detection?

Several immunoassay platforms can be employed for At3g06570 antibody detection, each with distinct advantages based on your research objectives:

Immunoassay MethodPrincipleRelative SensitivityRelative SpecificityBest Application Scenario
ELISAEnzyme-linked detection90-100%85-100%Quantitative protein analysis in extracts
Immunofluorescence (IIF)Fluorescent antibody detection85-95%76-95%Subcellular localization studies
Dot Immunoassay (DIA)Spot testing on membrane85-95%80-95%Rapid screening of multiple samples
EliAAutomated enzyme fluoroimmunoassay95-100%90-100%High-throughput sample processing

How should At3g06570 antibody validation be performed before experimental use?

Proper validation of At3g06570 antibodies is crucial for ensuring experimental reliability. A comprehensive validation protocol should include:

  • Specificity testing: Verify antibody recognizes only the target protein using positive and negative controls

  • Sensitivity assessment: Determine the minimum detectable concentration of target protein

  • Cross-reactivity testing: Evaluate potential cross-reactivity with related proteins, particularly in plant systems with gene duplications

  • Reproducibility verification: Confirm consistent performance across multiple experiments and different antibody lots

For robust validation, employ multiple complementary techniques such as western blotting with recombinant At3g06570 protein, immunoprecipitation followed by mass spectrometry, and testing in Arabidopsis knockout/knockdown lines lacking At3g06570 expression. This multi-method approach helps establish antibody reliability before proceeding with complex experimental applications .

How do different antibody formats affect At3g06570 detection in complex plant tissues?

The antibody format significantly impacts detection efficiency of At3g06570 in plant tissues with complex matrices. Research indicates that antibody engineering approaches can optimize detection through several mechanisms:

Antibody class and subclass selection directly impacts tissue penetration and background signal. While IgG remains the standard format for most applications, engineered fragments like Fab, F(ab')2, or single-chain variable fragments (scFv) may provide superior tissue penetration in densely packed plant structures .

The valency of the antibody also affects detection sensitivity. Multivalent antibody formats can enhance avidity through multiple binding sites. For example:

When working with particularly recalcitrant plant tissues, consider antibody reformatting to optimize performance. Data from comparative studies suggests that engineered formats with plant-optimized Fc regions can reduce non-specific binding to plant cell walls while maintaining high target specificity .

What strategies can resolve contradictory results when using At3g06570 antibodies across different experimental conditions?

Contradictory results when using At3g06570 antibodies often stem from methodology variations. A systematic troubleshooting approach includes:

  • Protocol standardization: Document and control all experimental variables including:

    • Fixation conditions (duration, temperature, reagent concentration)

    • Antigen retrieval methods (chemical vs. heat-induced)

    • Blocking reagents (composition, concentration, duration)

    • Antibody concentration and incubation conditions

    • Detection systems (direct vs. indirect, amplification methods)

  • Cross-validation with multiple detection methods: When contradictory results emerge, employ orthogonal detection techniques to clarify findings:

Primary MethodComplementary MethodValidation Benefit
Western blotMass spectrometryConfirms protein identity and specificity
ImmunofluorescenceIn situ hybridizationCorrelates protein localization with mRNA expression
Co-immunoprecipitationProximity ligation assayValidates protein-protein interactions
ELISAProtein microarrayConfirms quantitative measurements across platforms
  • Genetic controls: Utilize Arabidopsis mutant lines (knockout, knockdown, or overexpression) to verify antibody specificity under your specific experimental conditions .

  • Epitope mapping: When results vary between antibody batches or sources, determine whether different epitopes are being recognized, which may be differentially accessible depending on protein conformation, post-translational modifications, or protein-protein interactions .

How can At3g06570 antibodies be optimized for dual-labeling experiments in plant cells?

Dual-labeling experiments allow simultaneous detection of At3g06570 along with other proteins of interest. Optimization strategies include:

  • Antibody species selection: Choose At3g06570 antibodies from different host species than your second target antibody (e.g., rabbit anti-At3g06570 with mouse anti-second target) to enable simple secondary antibody discrimination.

  • Sequential immunostaining: When antibodies are from the same species, employ sequential staining protocols with intermediate blocking steps to prevent cross-reactivity3.

  • Isotype-specific secondary antibodies: Utilize secondary antibodies that recognize specific isotypes (e.g., IgG1 vs. IgG2a) when primary antibodies are from the same species but different isotypes .

  • Fragment-based approaches: Use F(ab')2 or Fab fragments of one antibody to reduce steric hindrance when targeting closely positioned epitopes.

When designing dual-labeling experiments, careful controls must be included to verify that signal co-localization represents true biological phenomena rather than technical artifacts from antibody cross-reactivity or spectral overlap between fluorophores.

What are the optimal fixation and antigen retrieval methods for At3g06570 immunodetection in plant tissues?

The effectiveness of At3g06570 immunodetection in plant tissues depends significantly on fixation and antigen retrieval methods, which must be optimized for the unique characteristics of plant cell walls and vacuoles:

  • Fixation optimization:

    FixativeRecommended ConcentrationPreservation of At3g06570 StructurePreservation of Cellular Context
    Paraformaldehyde2-4%Good epitope preservationModerate structural preservation
    Glutaraldehyde0.1-0.5% (in combination with PFA)Variable epitope preservationExcellent structural preservation
    Methanol100% (ice-cold)Good for cytoskeletal proteinsPoor membrane preservation
    Acetone100% (ice-cold)Variable epitope preservationModerate structural preservation
  • Antigen retrieval methods:

    • Heat-induced epitope retrieval (HIER): Using citrate buffer (pH 6.0) or Tris-EDTA (pH 9.0)

    • Enzymatic retrieval: Using proteases like proteinase K or trypsin

    • Detergent permeabilization: Using Triton X-100, Tween-20, or saponin

For At3g06570, which is often associated with membrane structures in plant cells, a combination approach is typically most effective. Initial fixation with 4% paraformaldehyde followed by heat-induced epitope retrieval in citrate buffer provides reliable results across multiple plant tissue types. For recalcitrant samples, adding a mild enzymatic treatment after heat retrieval can further expose epitopes without compromising tissue integrity3 .

How should controls be designed for At3g06570 antibody experiments?

Robust experimental controls are essential for reliable interpretation of At3g06570 antibody experiments:

  • Positive controls:

    • Recombinant At3g06570 protein (for western blot and ELISA)

    • Transgenic Arabidopsis lines overexpressing At3g06570

    • Tissues known to express At3g06570 at high levels

  • Negative controls:

    • At3g06570 knockout or knockdown plants

    • Pre-immune serum from the same animal used to generate the antibody

    • Secondary antibody-only controls

    • Blocking peptide competition (pre-incubation of antibody with excess antigen)

  • Technical validation controls:

    • Isotype controls with irrelevant antibodies of the same isotype and concentration

    • Concentration gradient series to establish detection limits

    • Multiple detection methods to confirm observations

A complete experimental design should include controls that account for both biological variability and technical artifacts. By implementing comprehensive controls, researchers can distinguish specific At3g06570 detection from background signals or cross-reactivity with similar plant proteins .

What are the optimal sample preparation methods for detecting At3g06570 in different plant subcellular compartments?

Detection of At3g06570 in different subcellular compartments requires tailored sample preparation approaches:

When investigating At3g06570 localization, always verify the purity of subcellular fractions using established marker proteins specific to each compartment. This validation ensures that detected signals represent true compartmentalization rather than contamination between fractions3 .

How can quantitative analysis of At3g06570 be standardized across different plant developmental stages?

Standardizing At3g06570 quantification across developmental stages presents unique challenges due to varying tissue compositions and protein expression levels. A comprehensive standardization approach includes:

  • Reference gene selection:

    • Identify stable reference proteins across developmental stages

    • Common plant reference proteins include actin, tubulin, and GAPDH

    • Verify stability using geNorm or NormFinder algorithms

  • Quantification methods:

    MethodPrincipleAdvantagesLimitations
    Western blot densitometryImage analysis of band intensityVisual confirmation of specificitySemi-quantitative
    ELISAAntibody-based quantificationHigh sensitivity, quantitativeNo size confirmation
    Mass spectrometryPeptide identification and quantificationAbsolute quantification possibleComplex workflow
    Dot blot arraySpot intensity measurementHigh throughputSemi-quantitative
  • Standardization procedure:

    • Include recombinant At3g06570 protein standards on each assay

    • Construct standard curves spanning expected physiological concentrations

    • Normalize to total protein content and reference gene expression

    • Express results as relative units or absolute concentrations

  • Statistical validation:

    • Perform at least three biological replicates and technical duplicates

    • Apply appropriate statistical tests (ANOVA, t-test) for developmental comparisons

    • Calculate confidence intervals for each measurement

For reliable cross-stage comparisons, consider developing a normalization factor based on multiple reference proteins rather than relying on a single reference, as expression stability can vary across developmental contexts3 .

What are common pitfalls when using At3g06570 antibodies and how can they be addressed?

Researchers working with At3g06570 antibodies frequently encounter several technical challenges that can compromise experimental outcomes:

  • High background signal:

    • Cause: Insufficient blocking, excessive antibody concentration, or non-specific binding

    • Solution: Optimize blocking conditions (try 5% BSA or 5% milk), titrate antibody concentration, include 0.1-0.2% Tween-20 in wash buffers, and consider pre-absorbing antibody with plant extracts lacking At3g06570

  • Weak or absent signal:

    • Cause: Epitope masking, protein degradation, or insufficient antigen

    • Solution: Test multiple antigen retrieval methods, ensure fresh protease inhibitors in all buffers, increase protein loading, and try longer exposure times or more sensitive detection methods

  • Multiple bands or unexpected band patterns:

    • Cause: Post-translational modifications, splice variants, protein degradation, or cross-reactivity

    • Solution: Use genetic controls (knockout lines), perform peptide competition assays, and consider western blotting under non-reducing conditions to preserve epitope structure

  • Poor reproducibility:

    • Cause: Inconsistent sample preparation, antibody batch variation, or environmental factors

    • Solution: Standardize all protocols, aliquot antibodies to avoid freeze-thaw cycles, and include positive controls in every experiment

  • Fixation artifacts in immunohistochemistry:

    • Cause: Overfixation can mask epitopes, underfixation can compromise structure

    • Solution: Optimize fixation time and conditions for specific tissue types, test multiple fixatives, and explore alternative antigen retrieval methods

How can At3g06570 antibodies be adapted for proximity ligation assays to study protein-protein interactions?

Proximity Ligation Assay (PLA) is a powerful technique for studying in situ protein-protein interactions involving At3g06570. Adapting At3g06570 antibodies for PLA requires several considerations:

  • Antibody selection criteria:

    • Primary antibodies must be from different species (e.g., rabbit anti-At3g06570 and mouse anti-interacting protein)

    • Monoclonal antibodies often provide better specificity but may be limited to single epitopes

    • Verify antibodies work independently before combining in PLA

  • PLA optimization for plant tissues:

    • Cell wall permeabilization: Use increased detergent concentrations (0.3-0.5% Triton X-100)

    • Modified blocking: Include plant-specific blocking agents (5% BSA with 2% normal serum)

    • Extended incubation times: Allow for slower diffusion through plant tissue

    • Signal amplification: Optimize rolling circle amplification time for plant tissues

  • Technical controls for PLA validation:

    • Positive interaction control: Known interacting protein pairs

    • Negative controls: Omit one primary antibody, use non-interacting protein pairs

    • Competition control: Pre-incubate with blocking peptides

When implementing PLA for At3g06570 interactions, start with protoplasts before moving to intact tissues, as protoplasts provide easier access for antibodies and detection reagents. For in situ tissue applications, optimize tissue sectioning thickness (typically 5-8 μm) to balance structural integrity with reagent accessibility .

What approaches can improve At3g06570 antibody specificity for challenging applications?

Enhancing At3g06570 antibody specificity for demanding applications requires targeted optimization strategies:

  • Antibody affinity purification:

    • Immobilize recombinant At3g06570 protein on an affinity column

    • Pass crude antibody preparation through the column

    • Elute bound antibodies with low pH buffer or chaotropic agents

    • Neutralize immediately and buffer exchange into storage buffer

  • Epitope-specific purification:

    • Synthesize peptides representing specific At3g06570 epitopes

    • Purify antibodies using epitope-specific affinity chromatography

    • Test multiple epitope regions to identify optimal specificity

  • Negative selection strategies:

    • Pass antibodies through columns containing plant extracts from At3g06570 knockout lines

    • Remove antibodies that bind to non-specific targets

    • Repeat process several times to enrich for specific antibodies

  • Antibody engineering approaches:

    • Consider using recombinant antibody technology to clone and express the variable regions

    • Engineer chimeric or humanized antibodies with optimized properties

    • Explore nanobody or single-chain variable fragment (scFv) formats for improved tissue penetration

  • Cross-adsorption protocol:

    StepProcedurePurpose
    1Prepare extract from At3g06570 knockout plantsCreate adsorption matrix
    2Immobilize extract on membranes or beadsCreate solid-phase adsorption platform
    3Incubate diluted antibody with immobilized extractRemove cross-reactive antibodies
    4Collect unbound antibody fractionHarvest enriched specific antibodies
    5Test specificity with comparative western blotsValidate improved specificity

For specialized applications like super-resolution microscopy or single-molecule tracking, consider direct chemical conjugation of fluorophores to affinity-purified antibodies to eliminate secondary antibody variability and reduce the detection complex size .

How might new antibody engineering technologies enhance At3g06570 research?

Emerging antibody engineering technologies offer promising opportunities to advance At3g06570 research beyond current limitations:

  • Nanobody development: Similar to the breakthrough in HIV research using llama nanobodies, plant-specific nanobodies could revolutionize At3g06570 detection. Their small size (approximately 15 kDa) enables access to sterically restricted epitopes and enhanced tissue penetration in plant systems .

  • Bispecific antibody formats: Engineering antibodies that simultaneously target At3g06570 and another protein of interest could enable novel functional studies:

    • Co-localization analysis without secondary antibody complications

    • Forced proximity studies to analyze potential interaction partners

    • Targeted protein degradation by recruiting ubiquitin ligases

  • Antibody fragment technologies:

    • Single-chain variable fragments (scFv): ~25 kDa engineered antibodies with reduced immunogenicity

    • Fab fragments: ~50 kDa antigen-binding fragments with eliminated Fc-mediated effects

    • Site-specific conjugation: Precisely engineered attachment points for labels or functional groups

  • Recombinant expression systems:

    • Plant-based antibody production in tobacco or lettuce

    • Yeast or insect cell expression for plant-compatible glycosylation patterns

    • Cell-free protein synthesis for rapid antibody variant screening

  • CRISPR-enabled antibody engineering:

    • Precise genetic modification of antibody-producing cells

    • Targeted humanization of antibody framework regions

    • High-throughput screening of antibody variants

These emerging technologies could address current limitations in At3g06570 research by providing more specific detection, reduced background in plant tissues, and novel functionalities beyond simple antigen binding .

What experimental designs can effectively validate conflicting At3g06570 localization data?

When faced with conflicting data regarding At3g06570 subcellular localization, a strategic multi-method validation approach is essential:

  • Complementary localization methods:

    MethodPrincipleStrengthsLimitations
    Fluorescent protein fusionsDirect visualizationLive-cell imagingPotential fusion artifacts
    ImmunolocalizationAntibody-based detectionDetects endogenous proteinFixation artifacts
    Cell fractionation + Western blotBiochemical separationQuantitativeLoss of spatial information
    Proximity labeling (BioID/APEX)In vivo biotinylationIdentifies neighboring proteinsRequires genetic modification
    Electron microscopy immunogoldUltrastructural detectionNanometer resolutionComplex sample preparation
  • Genetic complementation strategy:

    • Generate At3g06570 knockout lines

    • Complement with At3g06570 variants containing different targeting sequences

    • Assess restoration of phenotype and protein localization

  • Inducible expression systems:

    • Develop transgenic lines with inducible At3g06570 expression

    • Track protein localization temporally after induction

    • Distinguish primary localization from secondary trafficking

  • Perturbation approaches:

    • Apply inhibitors of specific trafficking pathways

    • Assess effects on At3g06570 localization

    • Use temperature-sensitive trafficking mutants

By systematically implementing these complementary approaches, researchers can resolve conflicting localization data and establish a consensus model of At3g06570 subcellular distribution across different tissues, developmental stages, and environmental conditions3 .

What are the current limitations in At3g06570 antibody research and future prospects?

Current limitations in At3g06570 antibody research include challenges with specificity in complex plant matrices, variability between antibody batches, limited epitope accessibility in certain fixation conditions, and potential cross-reactivity with related plant proteins. Additionally, the plant cell wall presents unique barriers to antibody penetration that aren't encountered in animal systems.

Future research directions that show particular promise include:

  • Development of engineered antibody formats optimized for plant tissues, similar to how nanobodies have transformed HIV research through their ability to access sterically restricted epitopes .

  • Implementation of standardized validation protocols that incorporate genetic controls, multiple detection methods, and quantitative analysis to ensure reproducibility across laboratories.

  • Adoption of proximity-based labeling techniques that can overcome limitations of traditional antibody approaches by providing dynamic interaction data in living plant cells.

  • Integration of computational approaches for epitope prediction and antibody engineering to develop next-generation At3g06570-specific detection reagents with enhanced properties.

  • Establishment of community resources for sharing validated antibody protocols, reagents, and genetic materials to accelerate research in this field.

By addressing these limitations through innovative approaches, researchers will be able to gain deeper insights into At3g06570 function, regulation, and interactions within plant cellular networks .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.